Table 1.
General Characteristics Among Non-Elderly Adults With Cancer and/or ASCVD, From the National Health Interview Survey, 2013 to 2018
| Neither ASCVD Nor Cancer | Cancer Only | ASCVD Only | Both ASCVD and Cancer | |
|---|---|---|---|---|
| Sample | 127,875 | 6,887 | 6,093 | 971 |
| Weighted sample | 178,640,421 (91.1) | 8,865,357 (4.5) | 7,493,768 (3.8) | 1,173,167 (0.6) |
| Age category, yrs | ||||
| 18–39 | 61,680 (50.7) | 979 (14.3) | 717 (13.3) | 66 (7.8) |
| 40–64 | 66,195 (49.3) | 5,908 (85.7) | 5,376 (86.7) | 905 (92.2) |
| Sex | ||||
| Male | 59,431 (49.3) | 2,350 (36.2) | 3,390 (59.1) | 441 (48.7) |
| Female | 68,444 (50.7) | 4,537 (63.8) | 2,703 (40.9) | 530 (51.3) |
| Race/ethnicity | ||||
| Non-Hispanic White | 78,011 (61.7) | 5,626 (83.6) | 3,801 (64.9) | 762 (82.1) |
| Non-Hispanic Black | 17,463 (13.2) | 503 (6.4) | 1,146 (17.1) | 105 (9.3) |
| Non-Hispanic Asian | 8,184 (6.6) | 155 (2.5) | 177 (3.3) | 6 (0.5) |
| Hispanic | 22,416 (18.4) | 526 (7.5) | 838 (14.8) | 72 (8.1) |
| Family income | ||||
| Middle/high income | 77,946 (69.5) | 4,658 (77.9) | 2,724 (54.1) | 424 (54.3) |
| Low income | 42,332 (30.5) | 1,826 (22.1) | 3,059 (45.9) | 497 (45.7) |
| Education | ||||
| Some college or higher | 82,769 (64.6) | 4,777 (70.4) | 2,993 (50.2) | 543 (56.8) |
| HS/GED or less than HS | 44,652 (35.4) | 2,094 (29.6) | 3,076 (49.8) | 425 (43.2) |
| Insurance status | ||||
| Insured | 107,418 (85.3) | 6,327 (92.9) | 5,335 (87.9) | 887 (91.7) |
| Uninsured | 19,816 (14.7) | 544 (7.1) | 740 (12.1) | 79 (8.3) |
| Region | ||||
| Northeast | 20,323 (17.4) | 1,120 (17.3) | 894 (15.1) | 141 (15.8) |
| Midwest | 27,750 (22.2) | 1,602 (23.6) | 1,344 (23.6) | 213 (24.1) |
| South | 45,443 (36.3) | 2,379 (37.2) | 2,566 (42.7) | 415 (43.0) |
| West | 34,359 (24.0) | 1,786 (22.0) | 1,289 (18.6) | 202 (17.0) |
| CRF profile | ||||
| Optimal | 73,456 (61.2) | 2,952 (47.4) | 940 (17.9) | 142 (16.5) |
| Average | 41,420 (32.8) | 2,789 (41.2) | 2,637 (45.6) | 390 (45.2) |
| Poor | 8,187 (6.0) | 819 (11.3) | 2,131 (36.4) | 360 (38.3) |
| Comorbidities | ||||
| 0 | 88,643 (70.8) | 3,203 (48.3) | 2,149 (37.9) | 210 (25.0) |
| 1 | 29,926 (22.7) | 2,259 (32.8) | 1,950 (32.5) | 270 (28.6) |
| ≥2 | 9,306 (6.5) | 1,425 (18.9) | 1,994 (29.6) | 491 (46.4) |
| Years since cancer diagnosis | — | 6 (2–14) | — | 7 (2–16) |
| Years since cancer diagnosis | ||||
| 0 to ≤5 | — | 2,989 (44.7) | — | 400 (41.6) |
| >5 to ≤15 | — | 2,336 (33.8) | — | 287 (31.6) |
| >15 | — | 1,562 (21.5) | — | 284 (26.8) |
Values are n, n (%), or median (interquartile range). All p values for comparison between groups were <0.001.
ASCVD = atherosclerotic cardiovascular disease; CRF = cardiovascular risk factor; GED = general equivalency diploma; HS = high school.